Potentially 2000 patients on Daybue by the end of March 2024....

Potentially 2000 patients on Daybue by the end of March 2024. Just under 4 full Qrts of sales.
That is US$187,500,000 for the 4th Qrt. Plus milestones payments.

I thought that may attract some attention. A$281,250,000 in one Qrt.
About A$35,156,250 to NEU for the Qtr.

Many on the forum wonder why there is little enthusiam for NEU on the market.
If they were to come onto the forum they would be inspired by a moribund attitude of one week at a time.
Lets see what next Qrt does. There is still risk with take up etc etc.

What more do Acadia and Neuren need to do to spell out the enourmous success of the Daybue Rollout?

It is absolutely stellar and they have shown that it is going to continue to be stellar. Look at the trends!

I have extroplated them for you.

Are you invested in NEU? Do you want investors to get excited?

This share is ridiculously undervalued and under understood for what is being achieved atm.
And many of them are current supposedly large shareholders.

If current shareholders are circumspect, don`t expect outsiders to buy.

Frustrating.

.

.